Stereotactic radiotherapy of primary liver cancer and hepatic metastases

References

• Edmondson HA, Peters RL. Neoplasms of the liver. Diseases of the liver, L Schiff, E Schiff. J.B. Lippincott, Philadelphia 1987; 1109–58
   Google Scholar
• Lehnert T, Golling M. Indikationen und Ergebnisse der Lebermetastasenresektion. Radiologe 2001; 41: 40–8
   PubMedGoogle Scholar
• Fong Y, Cohen AM, Forter JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938–46
   PubMed Web of Science ®Google Scholar
• Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg 1999; 230: 309–21
   PubMed Web of Science ®Google Scholar
• Vogl T, Straub R, Eichler K, et al. Colorectal carcinoma metastases in liver: Laser-induced interstitial Thermotherapy - Local tumor control rate and survival data. Radiology 2004; 230: 450–8
   PubMed Web of Science ®Google Scholar
• Solbiati L, Livraghi T, Goldberg SM, et al. Percutanous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology 2001; 221: 159–66
   PubMed Web of Science ®Google Scholar
• Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69: 925–9
   PubMed Web of Science ®Google Scholar
• Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000; 18: 2210–8
   PubMed Web of Science ®Google Scholar
• Park HC, Seong J, Han KH, et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2002; 54: 150–5
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Näslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Acta Oncol 1995; 34: 861–70
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Göranson H, et al. Radiosurgery for tumors in the body: Clinical experience using a new method. J Radiosurgery 1998; 1: 63–74
   Google Scholar
• Herfarth KK, Debus J, Lohr F, et al. Stereotactic single dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 2001; 19: 164–70
   PubMed Web of Science ®Google Scholar
• Schefter T, Kavanagh B, Timmerman R, et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005; 62: 1371–8
   PubMed Web of Science ®Google Scholar
• Gunvén P, Blomgren H, Lax I. Radiosurgery for recurring liver metastases after hepatectomy. Hepato-Gastroenterology 2003; 50: 1201–4
   PubMedGoogle Scholar
• Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy of primary lung cancer and pulmonary metastases: A non-invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004; 60: 186–96
   PubMed Web of Science ®Google Scholar
• Wulf J, Haedinger U, Oppitz U, et al. Stereotactic boost irradiation for targets in the abdomen and pelvis. Radiother Oncol 2004; 70: 31–6
   PubMed Web of Science ®Google Scholar
• Lax I. Target dose versus extra-target dose in stereotactic radiosurgery. Acta Oncol 1993; 32: 453–7
   PubMed Web of Science ®Google Scholar
• Lax I, Blomgren H, Näslund I, et al. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994; 33: 677–83
   PubMed Web of Science ®Google Scholar
• Wulf J, Hädinger U, Oppitz U, et al. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 2000; 57: 225–36
   PubMed Web of Science ®Google Scholar
• Wulf J, Haedinger U, Oppitz U, et al. Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver. Radiother Oncol 2003; 66: 141–50
   PubMedGoogle Scholar
• Haedinger U, Krieger T, Flentje M, et al. Influence of the calculation model on dose distribution in stereotactic radiotherapy of pulmonary targets. Int J Radiat Oncol Biol Phys 2005; 61: 239–49
   PubMed Web of Science ®Google Scholar
• Haedinger U, Thiele W, Wulf J. Extracranial stereotactic radiotherapy: Evaluation of PTV coverage and dose conformity. Z Med Phys 2002; 12: 221–9
   PubMedGoogle Scholar
• Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001; 177: 645–55
   PubMed Web of Science ®Google Scholar
• Wulf J, Meyer J, Flentje M, et al. Adaptive radiotherapy in stereotactic radiotherapy of extracranial targets: Integration of CT-verification on the treatment couch using a dedicated software to calculate the current stereotactic coordinate including evaluation of breathing mobility. Int J Radiat Oncol Biol Phys 2004; 60(Suppl 1)337
   Google Scholar
• Herfarth KK, Bahner ML, Lohr F, et al. Stereotactic single dose radiation therapy of liver metastases: Effects on normal liver tissue. Strahlenther Onkol 1998; 174(Suppl 71)76
   Google Scholar
• StatSoft. STATISTICA für Windows [Computer-Programm-Handbuch]. 6.0 ed. Tulsa, OK: StatSoft, Inc. 2300 East 14th street, Tulsa OK 74104; 1998.
   Google Scholar
• Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003; 124: 1946–55
   PubMed Web of Science ®Google Scholar
• Wulf J, Baier K, Mueller G, et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005; 77: 83–7
   PubMed Web of Science ®Google Scholar
• Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradation for stage I Non-Small Cell Lung Carcinoma. Cancer 2004; 101: 1623–31
   PubMed Web of Science ®Google Scholar
• Herfarth KK, Debus J. Stereotaktische Strahlentherapie von Lebermetastasen. Der Chirurg 2005; 76: 564–9
   PubMedGoogle Scholar